期刊文献+

北京4家医院临床分离的肠球菌株的耐药性分析 被引量:18

Antimicrobial resistance of clinical isolates of enterococcus from four hospitals in Beijing
下载PDF
导出
摘要 目的 深入分析北京地区分离的肠球菌的耐药表型 ,为临床合理选药提供客观实验依据。方法 按照美国临床实验室标准化委员会 (NCCLS)推荐的方法和判断标准进行纸片扩散法药敏试验 ,并用WHONET5专用软件进行分析。结果 临床分离的肠球菌中 ,粪肠球菌和屎肠球菌分别占 80 7%和 17 1% ;居前四位分离出肠球菌的标本是尿液 (33 8% )、痰液 (2 3 5 % )、脓性分泌物 (9 8% )和血液 (4 4 % )。粪肠球菌、屎肠球菌对万古霉素、替考拉宁、呋喃妥因、氯霉素、氨苄西林 ;高浓度庆大霉素的耐药率分别是 2 0 %、 1 5 % ;1 4 %、2 6 % ;11 7%、 15 5 % ;4 4 3%、 2 3 5 % ;17 7%、 6 4 2 % ;4 7 4 %、 6 4 9%。结论 泌尿系统肠球菌感染最常见。粪肠球菌和屎肠球菌对万古霉素、替考拉宁的耐药率低 ,治疗重症感染者可优先选药 ;对呋喃妥因有较好的敏感性 ; Objective The aim of the present study was to analyze the antimicrobial resistance of enterococcal isolates from four hospitals in Beijing in order to guide the selection and use of antimicrobial agents Methods enterococcus resistance testing was performed by the disk diffusion method recommended by NCCLS Laboratory data was analyzed by WHONET5 statistic software Results The isolates of E faecalis and E faecium were 80 7% ?17 1% of all enterococcus isolates, respectively The enterococcal isolates from urine?sputum?secretion with pus and blood were 33 8%?23 5%?9 8% and 4 4% of the total isolates,respectively The resistance rate of E faecalis and E faecium to Vancomycin?Teicoplanin?Nitrofurantoin?chloramphenicol ?Ampicillin?high -level gentamicin were 2 0%?1 5%;1 4%?2 6%;11 7%?15 5%;44 3%?23 5%;17 7%?64 2%;47 4%?64 9%, respectively Conclusion Urinary infections caused by enterococcus are most frequent E faecaliis and E facium have low resistance to Vancomycin and Teicoplanin,the two drugs should be selected prior to other agents to treat severe infections They have high susceptibility rate to nitrofurantoin and high resistance rate to high- level gentamicin and streptomycin
出处 《临床和实验医学杂志》 2002年第4期227-230,共4页 Journal of Clinical and Experimental Medicine
基金 北京市自然科学基金部分资助 (70 12 0 13)项目
关键词 医院 临床分离 肠球菌株 耐药性 抗生素 Enterococcus Antimicrobial resistance Antimicrobial agents
  • 相关文献

参考文献24

  • 1Emory TG;Gaynes RP.An overview of nosocomial infections including the rile of the microbiology laboratory,1993.
  • 2Weinstein M P.Comparative evaluation of penicillin ampicillin and imipenem MICs and susceptibility breakpoints for vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis and Enterococcus faecium[J],2001(07).
  • 3Schouten MA;Hoogkamp-Korstanje JA;Meis JF.Prevalence of vancomycin-resistant enterococci in Europe[J],2000(11).
  • 4Low DE;Keller N;Barth A.Clinical prevalence antimicrobial susceptibility and geographic resistance patterns of enterococci:results from the SENTRY Antimicrobial Surveillance Program 1997-1999[J],2001.
  • 5Melocristino J.Antimicrobial resistance in Staphlococci and Enterococci in 10 portuguse hospitals in 1996-1997,1998.
  • 6刘敏,赵成艳,高泽斌,于丽敏.300例肿瘤患者痰培养及药敏结果的分析[J].中国微生态学杂志,1996,8(6):31-32. 被引量:6
  • 7Papaparaskevas J;Vatopoulos A;Tassios PT.Diversity among high-level aminoglycoside-resistant enterococci[J],2000(03).
  • 8Elsner HA;Solbottka I;Feucht HH.In vitro susceptibilities of entercccocal blood culture isolates from the Hamburg area to ten antibiotics[J],2000(02).
  • 9王清涛,徐英春,王辉,陈民钧,张秀珍,许淑珍,吴坚.肠球菌耐药现状调查及抗感染用药探讨[J].中华医学检验杂志,1999,22(3):154-156. 被引量:132
  • 10Murray RE.Diversity among multidrug-resistant enterococci[J],1998.

二级参考文献146

共引文献242

同被引文献168

引证文献18

二级引证文献128

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部